Original ArticleTreatment Outcomes by Tumor Histology in Eastern Cooperative Group Study E4599 of Bevacizumab with Paclitaxel/Carboplatin for Advanced Non-small Cell Lung Cancer
Under an Elsevier user license
open archive
Key Words
Non-small cell lung cancer
Bevacizumab
Nonsquamous
Histology
Adenocarcinoma
Cited by (0)
Disclosure: Alan Sandler, MD, received a grant for this study and serves as a consultant and on the advisory board for Genentech. Jing Yi, PhD, and her husband are employed by Genentech. Margaret M. Kolb, DrPH, serves as a paid consultant to Genentech. Lisa Wang, PhD, and Julie Hambleton, MD, are employed by and hold stock in Genentech. Joan Schiller, MD, serves on the advisory board for Genentech. The other authors declare no conflicts of interest.
Presented as an abstract (a portion of the tumor histology analysis described in this article) at the International Association of Lung Cancer Annual Meeting in Chicago, IL, 2008.
Copyright © 2010 International Association for the Study of Lung Cancer. All rights reserved.